Skip to main content
logo
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3269
+0.0369 (12.72%)
Sep 11, 2026, 4:00 PM EDT - Market closed

AEON Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1613222681,395214
Market Cap Growth
89.51%-39.67%-91.93%-80.82%553.24%-
Enterprise Value
1625382521,642428
Last Close Price
0.331.1038.88518.40723.60699.12

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.51---
PB Ratio
--0.24-0.76-1.75-10.53-2.49

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.18-0.65-0.450.00-0.99-1.01
Net Debt / Equity Ratio
0.04-0.59-0.450.03-0.92-0.95
Net Debt / EBITDA Ratio
0.03-2.02-0.470.09-2.52-2.22
Net Debt / FCF Ratio
0.05-1.89-0.640.10-3.40-2.86
Quick Ratio
0.470.440.000.400.120.25
Current Ratio
0.540.490.110.480.120.25
Return on Assets (ROA)
-141.53%-234.17%-348.25%-374.77%-351.67%-166.73%
Return on Capital Employed (ROCE)
1389.40%1219.30%252.80%851.60%67.50%256.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-334.97%-301.19%194.61%-143.76%-3.77%-26.05%
FCF Yield
-83.66%-132.94%-94.01%-17.88%-2.57%-13.39%
Buyback Yield / Dilution
-613.82%-1622.66%99.25%-3896.62%-9.98%-1813.85%
SEC Filings: 10-K · 10-Q